• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择用于无菌配制的药瓶处理生产线:第1部分。

Choosing a Vial Processing Line for Aseptic Compounding: Part 1.

作者信息

Noorian Shaun, Vahedi Navid

机构信息

Empower Pharmacy, Houston, Texas.

Fusion IV Compounding Pharmacy, Los Angeles, California.

出版信息

Int J Pharm Compd. 2016 Jul-Aug;20(4):283-292.

PMID:28333673
Abstract

Equipment systems that enable compliance with stringent state and federal compounding requirements are a topic of increasing interest to U.S. pharmacists. Of those equipment types, an aseptic vial processing line offers unique benefits (especially to 503B compounding pharmacies and small contract manufacturers of aseptic pilot-size batches) if the volume of sterile preparations dispensed offsets the cost of purchase, installation, and maintenance. In this article, the reasons for and the process of selecting an aseptic vial processing line for use in 2 independent 503B compounding pharmacies are presented, the operation of our choice of equipment is described, and specifications for the components of that line are listed. In part 2 of this series, the success of our choice and its effect on sterile compounding in our facilities will be reported.

摘要

能够符合严格的州和联邦配制要求的设备系统,越来越受到美国药剂师的关注。在这些设备类型中,如果无菌制剂的配量能够抵消购买、安装和维护成本,无菌小瓶生产线会带来独特的益处(尤其对于503B配制药房和无菌中试规模批次的小型合同制造商)。本文介绍了在两家独立的503B配制药房中选择无菌小瓶生产线的原因和过程,描述了我们所选设备的操作,并列出了该生产线组件的规格。在本系列的第2部分中,将报告我们所选设备的成功之处及其对我们设施中无菌配制的影响。

相似文献

1
Choosing a Vial Processing Line for Aseptic Compounding: Part 1.选择用于无菌配制的药瓶处理生产线:第1部分。
Int J Pharm Compd. 2016 Jul-Aug;20(4):283-292.
2
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding.
Int J Pharm Compd. 2016 Jul-Aug;20(4):307-314.
3
Does your pharmacy have a compounding isolator?你们药房有复方隔离器吗?
Am J Health Syst Pharm. 2007 Apr 15;64(8):855-8. doi: 10.2146/ajhp060148.
4
Sterile Product Packaging and Delivery Systems.无菌产品包装与输送系统
Int J Pharm Compd. 2015 Nov-Dec;19(6):491-500.
5
Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.紊流和单向气流复合无菌隔离器中空气传播污染的可能性。
Am J Health Syst Pharm. 2007 Mar 15;64(6):622-31. doi: 10.2146/ajhp060067.
6
End-preparation assessments and tests for compounded sterile preparations.复方无菌制剂的终末配制评估与测试
Int J Pharm Compd. 2013 Jul-Aug;17(4):307-11.
7
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.美国食品药品监督管理局检查:503A无菌配制药房成功应对指南
Int J Pharm Compd. 2017 Mar-Apr;21(2):95-102.
8
Traditional vs. nontraditional pharmacy.传统药房与非传统药房。
Int J Pharm Compd. 2013 Jul-Aug;17(4):351.
9
Microbiological validation of a robot for the sterile compounding of injectable non-hazardous medications in a hospital environment.在医院环境中,对机器人进行无菌配制注射用非危险药物的微生物学验证。
Eur J Hosp Pharm. 2020 Mar;27(e1):e63-e68. doi: 10.1136/ejhpharm-2018-001757. Epub 2019 Feb 4.
10
Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.两种工作实践改变对药房配制无菌制剂微生物污染率的影响。
Am J Health Syst Pharm. 2007 Apr 15;64(8):837-41. doi: 10.2146/060199.